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A 45-year-old Swiss commercial clerk consulted his GP
with progressive dyspnoea at exertion. Clinical examination
revealed multiple raised purple plaques on the face and
extremities (Fig. 1a) and multiple round, livid lesions of the
tongue and oropharynx (Fig. 1b). Sexual history was sig-
nificant for multiple prior homosexual partners. No personal
history. A chest computed tomography (CT) scan showed
multiple pulmonary infiltrates and mediastinal lympha-
denopathia (Fig. 1c). HIV screening was positive. Tubercle
bacilli tested negative in three sputa by direct microscopy.
A bronchoscopy was performed, revealing typical Kaposi’s
lesions in the upper and lower respiratory tract (Fig. 1d).
The patient’s CD4 cell count was 143/ll. HIV viral load
and HHV-8 viral load in plasma was 135,028 k/ml and
1,565 k/ml, respectively. The patient was started on anti-
retroviral treatment with ritonavir-boosted atazanavir,
emtricitabine and tenofovir. Ten days later, the patient was
re-admitted to the hospital due to progressive dyspnoea.
Clinical examination revealed progression of the oral
Kaposi lesions. Arterial blood gas analysis confirmed
severe partial respiratory insufficiency (arterial partial
pressure of oxygen [paO2] = 6 kPa breathing ambient air).
CT chest scanning showed radiological progression of
pulmonary infiltrates. Chemotherapy with doxorubicin
20 mg/m2 body surface area on a 2-weekly schedule was
started. Surgical resection of the oropharyngeal Kaposi
lesions was performed. Respiratory function readily
improved upon treatment. The patient’s symptoms steadily
improved from the first cycle of doxorubicin. Staging CT
scanning will be performed after six cycles of chemotherapy.
We report this case to illustrate the diverse clinical
features of disseminated Kaposi’s sarcoma in an HIV-
positive late presenter.
Conflict of interest The authors declare no conflict of interest.
Fig. 1 a Cutaneous Kaposi lesions. b Kaposi lesions of the tongue
and oropharynx. c Computed tomography (CT) chest scan showing
pulmonary Kaposi infiltrates. d Pathognomonic Kaposi’s lesions of
the bronchial system
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